nach oben

International Journal of Diabetes in Developing Countries

Erschienen in:

06.11.2019 | Original Article

Genetic polymorphism of eNOS (G894T) gene in insulin resistance in type 2 diabetes patients of Pakistani population

verfasst von: Abdullah Abdo Albegali, Muhammad Shahzad, Saqib Mahmood, Muhammad Ikram Ullah, Ali Amar, Osheen Sajjad

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Insulin resistance associated with type 2 diabetes (T2DM) consequences in the development of metabolc syndrome. Due to the complex mechanism, various pathogenic factors like enviromental and genetic predispositon contribute to the disease pathogenicity. The reduced availability of eNOS has been determined as a mark of insulin resistance pathogenesis.

Objective

The objctive of this study was to investigate genetic polymorphism of eNOS (rs1799983; G894T) with susceptibility of insulin resistance in type 2 diabetes (T2DM) patients from Pakistani population.

Methods

Total of 322 (161 T2DM cases and 161 healthy controls) subjects were recruited for this study. Genomic DNA extraction was carried out by standard phenol-chloroform protocols. PCR amplification of the unique oligonucleotides of eNOS gene was done and restriction fragment analysis (RFLP) was performed by site-specific enzyme BanII.

Results

The frequency of GG (wild genotype) was higher (77.6%) in cases than in controls (47.2%), heterozygous GT genotype higher in controls than patients (OR = 0.26, p < 0.0005 and after adjustment, OR = 0.34, p = 0.091). Different genetic models like dominant model of GT&TT was higher in controls than patients (OR 0.26, p < 0.0005; OR 0.29, p = 0.038 respectively) and log-additive model indicated the significant protective effect of the genotype before and after adjustment for the confounding factors.

Conclusion

This study demonstrates that there is no association between eNOS rs1799983 polymorphism and insulin resistance in T2DM patients of Pakistani population.

Roberts CK, Hevener AL, Barnard RJ. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol. 2013;3(1):1–58. https://doi.org/10.1002/cphy.c110062.CrossRefPubMedPubMedCentral

Zafar U, Khaliq S, Ahmad HU, Lone KP. Serum profile of cytokines and their genetic variants in metabolic syndrome and healthy subjects: a comparative study. Biosci Rep. 2019;39(2):BSR20181202. https://doi.org/10.1042/BSR20181202.CrossRefPubMedPubMedCentral

Bae J, Kim IJ, Hong SH, Sung JH, Lim SW, Cha DH. Association of endothelial nitric oxide synthase polymorphisms with coronary artery disease in Korean individuals with or without diabetes mellitus. Exp Ther Med. 2010;1:719–24.CrossRefPubMedPubMedCentral

Chandrasekaran S, Sivani S, Sudarsanam D. Evaluation of single nucleotide polymorphism C825T in the GNB3 gene with the development of type 2 diabetes of the South Indian population. Int J Pharm Sci Res. 2012;13(1):249–57.

Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J. 2001;357(Pt 3):593–615.CrossRefPubMedPubMedCentral

Guzik TJ, Black E, West NE, McDonald D, Ratnatunga C, Pillai R. Relationship between the G894T polymorphism (Glu298Asp variant) in endothelial nitric oxide synthase and nitric oxide-mediated endothelial function in human atherosclerosis. Am J Med Genet. 2001;100(2):130–7.CrossRefPubMed

Huang PL. eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol Metab. 2009;20(6):295–302. https://doi.org/10.1016/j.tem.2009.03.005.CrossRefPubMedPubMedCentral

Angeline T, Krithiga HR, Isabel W, Asirvatham AJ, Poornima A. Endothelial nitric oxide synthase gene polymorphism (G894T) and diabetes mellitus (type II) among South Indians. Oxidative Med Cell Longev. 2011;2011:462607. https://doi.org/10.1155/2011/462607.CrossRef

Guo X, Cheng S, Taylor KD, Cui J, Hughes R, Quiñones MJ. Hypertension genes are genetic markers for insulin sensitivity and resistance. Hypertension. 2005;45(4):799–803.CrossRefPubMed

10.

Demova H, Daniela JB, Hannes R, Bohumir K, Ludmila P, Ivan B. Gene polymorphisms in patients with type 2 diabetes and diabetic nephropathy. Cent Eur J Biol. 2012;7(2):210–8.

11.

Conen D, Glynn RJ, Buring JE, Ridker PM, Zee RY, et al. Reninangiotensin and endothelial nitric oxide synthase gene polymorphisms are not associated with the risk of incident type 2 diabetes mellitus: a prospective cohort study. J Intern Med. 2008;263(4):376–85.CrossRefPubMed

12.

Dlugos AM, Hamidovic A, Palmer AA, de Wit H. Further evidence of association between amphetamine response and SLC6A2 gene variants. Psychopharmacology. 2009;206:501–11.CrossRefPubMedPubMedCentral

13.

Dellamea BS, Pinto LCF, Leitão CB, Santos KG, Canani LHS. Endothelial nitric oxide synthase gene polymorphisms and risk of diabetic nephropathy: a systematic review and metaanalysis. BMC Med Genet. 2014;15:9.CrossRefPubMedPubMedCentral

14.

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.CrossRefPubMed

15.

Rizvi S, Raza ST, Rahman Q, Eba A, Zaidi ZH, Mahdi F. Association of endothelial nitric oxide synthase (eNOS) and norepinephrine transporter (NET) genes polymorphism with type 2 diabetes mellitus. Mol Biol Rep. 2019;46(5):5433–5441. https://doi.org/10.1007/s11033-019-04998-y.

16.

Erdogan M, Kulaksizoglu M, Tetik A, Solmaz S, Kucukaslan AS, Eroglu Z. The relationship of the endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor (VEGF) gene polymorphism in Turkish type 2 diabetic patients with and without diabetic foot ulcers. Foot (Edinb). 2018;37:5–10. https://doi.org/10.1016/j.foot.2018.06.006.CrossRef

17.

Sadati SM, Radfar M, Hamidi AK, Abdollahi M, Qorbani M, Esfahani EN, et al. Association between the polymorphism of Glu298Asp in exon 7 of the eNOS gene with foot ulcer and oxidative stress in adult patients with type 2 diabetes. Can J Diabetes. 2018;42(1):18–22. https://doi.org/10.1016/j.jcjd.2017.03.001.CrossRefPubMed

18.

Moguib O, Raslan HM, Abdel Rasheed I, Effat L, Mohamed N, El Serougy S, et al. Endothelial nitric oxide synthase gene (T786C and G894T) polymorphisms in Egyptian patients with type 2 diabetes. J Genet Eng Biotechnol. 2017;15(2):431–6. https://doi.org/10.1016/j.jgeb.2017.05.001.CrossRefPubMedPubMedCentral

19.

Li JY, Tao F, Wu XX, Tan YZ, He L, Lu H. Polymorphic variations in manganese superoxide dismutase (MnSOD) and endothelial nitric oxide synthase (eNOS) genes contribute to the development of type 2 diabetes mellitus in the Chinese Han population. Genet Mol Res. 2015;14(4):12993–3002. https://doi.org/10.4238/2015.October.21.20.CrossRefPubMed

20.

Mackawy AM, Khan AA, Badawy M-S. Association of the endothelial nitric oxide synthase gene G894T polymorphism with the risk of diabetic nephropathy in Qassim region, Saudi Arabia-a pilot study. Meta Gene. 2014;2:392–402. https://doi.org/10.1016/j.mgene.2014.04.009.CrossRefPubMedPubMedCentral

21.

Albegali AA, Shahzad M, Mahmood S, Ullah MI. Genetic association of insulin receptor substrate-1 (IRS-1, rs1801278) gene with insulin resistant of type 2 diabetes mellitus in a Pakistani population. Mol Biol Rep. 2019. https://doi.org/10.1007/s11033-019-05041-w.

22.

Ansarimoghaddam A, Adineh HA, Zareban I, Iranpour S, HosseinZadeh A, Kh F. Prevalence of metabolic syndrome in Middle-East countries: Meta-analysis of cross-sectional studies. Diabetes Metab Syndr. 2018;12(2):195–201.CrossRefPubMed

23.

Konsola T, Siasos G, Antonopoulos AS, Kollia C, Oikonomou E, Tentolouris N, et al. The impact of T786C and G894T polymorphisms of eNOS on vascular endothelial growth factor serum levels in type 2 diabetes patients. Int J Cardiol. 2016;222:155–6. https://doi.org/10.1016/j.ijcard.2016.07.238.CrossRefPubMed

24.

Delli Muti N, Tirabassi G, Lamonica GR, Lenzi A, Balercia G. Diabetes mellitus and late-onset hypogonadism: the role of Glu298Asp endothelial nitric oxide synthase polymorphism. Andrologia. 2015;47(8):867–71. https://doi.org/10.1111/and.12339.CrossRefPubMed

25.

Yoshimura T, Hisatomi A, Kajihara S, Yasutake T, Ogawa Y, Mizuta T, et al. The relationship between insulin resistance and polymorphisms of the endothelial nitric oxide synthase gene in patients with coronary artery disease. J Atheroscler Thromb. 2003;10(1):43–7.CrossRefPubMed

26.

Santos KG, Crispim D, Canani LH, Ferrugem PT, Gross JL, Roisenberg I. Relationship of endothelial nitric oxide synthase (eNOS) gene polymorphisms with diabetic retinopathy in Caucasians with type 2 diabetes. Ophthalmic Genet. 2012;33(1):23–7.CrossRefPubMed

27.

Shah VN, Cheema BS, Kohli HS, Sharma R, Khullar M, et al. Endothelial nitric oxide synthase gene polymorphism and the risk of diabetic neuropathy in Asian Indian patients with type 2 diabetes. J Diabetes Metab. 2013;4:243.CrossRef

28.

Srivastava K, Biswas UK, Narang R, Varghese JJ, Das N. Prevalence of eNOS Glu298Asp polymorphism in healthy volunteers from a region of northern India. Community Genet. 2005;8:180–3.PubMed

29.

Garme Y, Moudi M, Saravani R, Galavi H. Nitric oxide synthase 2 polymorphisms (rs2779248T/C and rs1137933C/T) and the risk of type 2 diabetes in Zahedan, Southeastern Iran. Iran J Public Health. 2018;47(11):1734–41.PubMedPubMedCentral

30.

de Syllos RW, Sandrim VC, Lisboa HR, Tres GS, Tanus-Santos JE. Endothelial nitric oxide synthase genotype and haplotype are not associated with diabetic retinopathy in diabetes type 2 patients. Nitric Oxide. 2006;15(4):417–22.CrossRefPubMed

31.

Monti LD, Barlassina C, Citterio L, Galluccio E, Berzuini C, Setola E, et al. Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes. 2003;52(5):1270–5.CrossRefPubMed

32.

Rittig K, Holder K, Stock J, Tschritter O, Peter A, Stefan N, et al. Endothelial NO-synthase intron 4 polymorphism is associated with disturbed in vivo nitric oxide production in individuals prone to type 2 diabetes. Horm Metab Res. 2008;40(1):13–7.CrossRefPubMed

Titel: Genetic polymorphism of eNOS (G894T) gene in insulin resistance in type 2 diabetes patients of Pakistani population
verfasst von: Abdullah Abdo Albegali
Muhammad Shahzad
Saqib Mahmood
Muhammad Ikram Ullah
Ali Amar
Osheen Sajjad
Publikationsdatum: 06.11.2019
Verlag: Springer India
Erschienen in: International Journal of Diabetes in Developing Countries / Ausgabe 2/2020
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI: https://doi.org/10.1007/s13410-019-00775-6

Post COVID-19 diabetes care—lessons and challenges

Zur Zeit gratis
COVID-19
Editorial

Phenotypic characterization of patients with type 2 diabetes mellitus

Original Article

Prevalence and predictors of osteopenia and osteoporosis in patients with type 2 diabetes mellitus: a cross-sectional study from a tertiary care institute in North India

Original Article

Liver iron concentration is an independent risk factor for the prediabetic state in β-thalassemia patients

Original Article

Combination of negative pressure wound therapy using vacuum-assisted closure and ozone water flushing for treatment of diabetic foot ulcers

Original Article

Assessment of risk for obstructive sleep apnea by using STOP-BANG questionnaire in type 2 diabetes mellitus

Original Article

Springer Medizin

Genetic polymorphism of eNOS (G894T) gene in insulin resistance in type 2 diabetes patients of Pakistani population

Abstract

Background

Objective

Methods

Results

Conclusion

Weitere Artikel der Ausgabe 2/2020

Post COVID-19 diabetes care—lessons and challenges

Phenotypic characterization of patients with type 2 diabetes mellitus

Prevalence and predictors of osteopenia and osteoporosis in patients with type 2 diabetes mellitus: a cross-sectional study from a tertiary care institute in North India

Liver iron concentration is an independent risk factor for the prediabetic state in β-thalassemia patients

Combination of negative pressure wound therapy using vacuum-assisted closure and ozone water flushing for treatment of diabetic foot ulcers

Assessment of risk for obstructive sleep apnea by using STOP-BANG questionnaire in type 2 diabetes mellitus

Springer Medizin

Abstract

Background

Objective

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Post COVID-19 diabetes care—lessons and challenges

Phenotypic characterization of patients with type 2 diabetes mellitus

Prevalence and predictors of osteopenia and osteoporosis in patients with type 2 diabetes mellitus: a cross-sectional study from a tertiary care institute in North India

Liver iron concentration is an independent risk factor for the prediabetic state in β-thalassemia patients

Combination of negative pressure wound therapy using vacuum-assisted closure and ozone water flushing for treatment of diabetic foot ulcers

Assessment of risk for obstructive sleep apnea by using STOP-BANG questionnaire in type 2 diabetes mellitus